Accuracy of the Pain Numeric Rating Scale as a Screening Test in Primary Care by Krebs, Erin E. et al.
Accuracy of the Pain Numeric Rating Scale as a Screening
Test in Primary Care
Erin E. Krebs, MD, MPH1,2,3, Timothy S. Carey, MD, MPH4,5, and Morris Weinberger, PhD6,7
1Center on Implementing Evidence-Based Practice, Roudebush Veterans Affairs Medical Center, Indianapolis, IN, USA; 2Center for Health
Services and Outcomes Research, Regenstrief Institute, Inc., Indianapolis, IN, USA; 3Department of Medicine, Indiana University School of
Medicine, Indianapolis, IN, USA; 4Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA;
5Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA; 6Health Policy and Administration, University
of North Carolina School of Public Health, Chapel Hill, NC, USA; 7Center for Health Services Research in Primary Care, Durham Veterans Affairs
Medical Center, Durham, NC, USA.
BACKGROUND: Universal pain screening with a 0–10
pain intensity numeric rating scale (NRS) has been
widely implemented in primary care.
OBJECTIVE: To evaluate the accuracy of the NRS as a
screening test to identify primary care patients with
clinically important pain.
DESIGN: Prospective diagnostic accuracy study
PARTICIPANTS: 275 adult clinic patients were enrolled
from September 2005 to March 2006.
MEASUREMENTS: We operationalized clinically impor-
tant pain using two alternate definitions: (1) pain that
interferes with functioning (Brief Pain Inventory inter-
ference scale≥5) and (2) pain that motivates a physi-
cian visit (patient-reported reason for the visit).
RESULTS: 22% of patients reported a pain symptom as
the main reason for the visit. The most common pain
locations were lower extremity (21%) and back/neck
(18%). The area under the receiver operator character-
istic curve for the NRS as a test for pain that interferes
with functioning was 0.76, indicating fair accuracy. A
pain screening NRS score of 1 was 69% sensitive (95%
CI 60–78) for pain that interferes with functioning.
Multilevel likelihood ratios for scores of 0, 1–3, 4–6,
and 7–10 were 0.39 (0.29–0.53), 0.99 (0.38–2.60), 2.67
(1.56–4.57), and 5.60 (3.06–10.26), respectively.
Results were similar when NRS scores were evaluated
against the alternate definition of clinically important
pain (pain that motivates a physician visit).
CONCLUSIONS: The most commonly used measure for
pain screening may have only modest accuracy for
identifying patients with clinically important pain in
primary care. Further research is needed to evaluate
whether pain screening improves patient outcomes in
primary care.
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INTRODUCTION
Universal pain screening is an increasingly common practice,
largely because of the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO) requirement that accred-
ited hospitals and clinics must routinely assess all patients for
pain.1 Pain screening is intended to improve the quality of pain
management by systematically identifying patients with pain
in clinical settings.2
Pain symptoms are among the most common complaints in
primary care and are diverse in terms of etiology, severity, and
duration. Approximately 20% of primary care patients suffer
from chronic pain;3 however, many pain symptoms in primary
care are minor and transient.4 Universal screening in primary
care would be useful if it accurately identified patients with
clinically important pain who could potentially benefit from
additional pain assessment and management.
JCAHO standards do not specify how pain should be
assessed; rather, they allow organizations to develop their
own pain assessment policies.5 The pain numeric rating scale
(NRS), on which patients rate their current pain intensity from
0 (“no pain”) to 10 (“worst possible pain”), has become the most
widely used instrument for pain screening. Although it was not
developed or validated as a screening test, the NRS is
ubiquitous as a screener in many health care environments.
For example, its use is currently mandated throughout the
Veterans Affairs health care system as part of its “Pain as the
fifth vital sign” campaign.6
The NRS has potential advantages as a screening test. It is
short, easy to administer, and has been validated as a measure
of pain intensity in populations with known pain.7,8 However,
no studies have evaluated its accuracy as a screening test to
identify patients with clinically important pain. The U.S.
Preventive Services Task Force (USPSTF) recommends that
two criteria be met before a screening test is recommended for
widespread use: (1) the test should be sufficiently accurate and
capable of detecting a condition earlier than routine care and,
(2) screening and early treatment should improve the likeli-
hood of favorable patient outcomes.9 We designed this study to
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address the first criterion, that is, to evaluate the accuracy of
the NRS as a screening test to identify primary care patients
with clinically important pain.
MATERIALS AND METHODS
Participants
We enrolled participants from September 2005 to March 2006
at the University of North Carolina (UNC) at Chapel Hill
General Internal Medicine clinic. Adult patients presenting to
clinic for a return visit were eligible to participate. We excluded
patients who did not speak English because very few non-
English speaking patients attend the clinic and because
resource constraints prevented us from providing the survey
in multiple languages. We obtained permission from physi-
cians in the clinic to approach patients on their schedules and
allowed physicians to opt out individual patients. Participants
provided written informed consent. The UNC Biomedical
Institutional Review Board approved the study protocol.
Procedures
In accordance with UNC policy, patients are screened for
current pain with the 0–10 NRS at the time of vital sign
measurement. Patients then return to the waiting room or go
to an examination room to wait for the physician. A research
assistant approached patients during this waiting time and
invited them to enroll in the study. Consecutive available
patients were invited to participate during times when a
research assistant was present in the clinic. To ensure
adequate numbers of patients reporting pain, we oversampled
those with pain screening NRS scores of≥1. Specifically, all
eligible patients were invited to enroll until we enrolled enough
patients with a pain screening score of zero to comprise
approximately 20% of the target sample size. Thereafter, only
patients with scores of≥1 were invited to participate.
To avoid alerting patients to the specific focus of the study,
research assistants invited them to participate in a study of
symptoms in primary care. After patients agreed to participate,
a research assistant elicited the reasons for the visit.
Participants were asked to return to a designated room in
clinic for the study interview immediately after completing
their physician visit. Because previous work in the clinic has
documented a high prevalence of low literacy,10 data were
collected by face-to-face interview. One research assistant, a
premedical student, conducted all interviews.
Nursing notes, dictated physician notes, and problem lists
were abstracted from the electronic medical record after the
interview was completed. Medical comorbidities were abstract-
ed from the problem list using a list of 10 common conditions
(arthritis, asthma/chronic lung disease, cancer, coronary
artery disease, diabetes, heart failure, hypertension, liver
disease, kidney disease, stroke).11
Measures
Pain screening NRS. At the time of vital sign measurement,
clinic staff members ask patients to rate the intensity of their
current pain on a scale of 0 (“no pain”) to 10 (“worst possible
pain”). Staff members then enter pain scores and other vital
signs into the electronic medical record. Because this study
was designed to evaluate the operating characteristics of pain
screening in real practice, we did not retrain clinic staff or alter
preexisting pain screening protocols. Based on previous
studies and clinical practice, we categorized pain screening
NRS scores as mild (1–3), moderate (4–6), or severe (7–10).
Studies of chronic pain patients with different conditions have
reached varying conclusions about the optimal cut points for
mild, moderate, and severe pain on the 0–10 NRS, with 4 or 5
being the most commonly recommended lower limits for
moderate pain and 7 or 8 for severe pain.12–17 We chose a
score of 4 as the lower limit for moderate pain because it is
most commonly accepted for clinical and administrative use.
Brief Pain Inventory (BPI) interference scale. The BPI was
administered during the study interview by a research
assistant. We selected the BPI interference scale because it
includes a generic measure of pain-related function that has
been used in many types of pain conditions, is relatively short
and easy to administer, and has been recommended as a core
outcome measure for pain studies.18–20 The BPI measures
pain-related functional impairment in 7 domains: general
activity, mood, walking ability, normal work, relations with
other people, sleep, and enjoyment of life. Possible scores for
each domain range from 0 (“does not interfere”) to 10
(“interferes completely”). The overall BPI interference score is
the mean of the 7 item scores. If one value was missing from a
given scale, we imputed missing values using best subset
regression. We did not impute values if more than one value
was missing.
The BPI includes an initial lead-in question about the
presence of pain: “Throughout our lives, most of us have had
pain from time to time (such as minor headaches, sprains, and
toothaches). Have you had pain other than these everyday
kinds of pain during the past week?” We were concerned that
using this lead-in question alone might exclude too many
patients from completing the full BPI. Therefore, we incorpo-
rated an additional question: “Have you had any pain at all,
including minor aches or pains, during the past week?”
Patients who answered “no” to both questions did not continue
with the full BPI and were assigned a score of 0.
Reasons for the visit. A research assistant asked two open-
ended questions before patients saw the physician: (1) “what is
the main reason for your visit today?” and (2) “what other
concerns would you like to talk to the doctor about today?”
Responses were classified as belonging to one of three
categories: pain symptom, nonpain symptom, or other.
Analysis
The purpose of this study was to evaluate the NRS as a
screening test for clinically important pain in primary care.
Because there is no gold standard definition of clinically
important pain, we operationalized it using two alternate
definitions: (1) pain that interferes with functioning and (2)
pain that motivates a physician visit.
For our first definition (pain that interferes with functioning),
we used a score of≥5 on the BPI interference scale as the
primary reference standard. Although prior studies have used
a BPI interference score of 4 or 5 as a cutoff,21,22 there is no
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consensus about what score constitutes substantial interfer-
ence. Therefore, we used a score of≥5 (the midpoint) and
conducted sensitivity analysis using different scores as alter-
native reference standards (BPI interference≥4; BPI interfer-
ence≥3; any single BPI interference item≥5). For the second
definition (pain that motivates a visit), we used our measure of
reasons for the visit. Patients who reported a pain problem as
the “main reason” or “other concern” were considered to have a
pain reason for the visit.
Based on our conservative a priori assumption that 20% of
the sample would have a BPI interference score≥5, we
calculated that enrollment of 310 subjects would be necessary
to estimate accuracy with a 95% confidence interval of ±0.10.
An interim evaluation of data from the first 213 participants
revealed that 46% had a BPI interference score≥5; therefore,
we lowered our recruitment target to 275 participants.
We fit receiver operator characteristic (ROC) curves for the
pain screening NRS compared to the reference standards for
clinically important pain and calculated the area under the
curve for each comparison. The area under the ROC curve is a
measure of overall accuracy for tests with continuous results,
where 0.5 indicates a worthless test and 1.0 a perfect (100%
accurate) test.
We calculated sensitivity and specificity for dichotomized
pain screening NRS cut points. We determined multilevel
likelihood ratios for pain screening NRS categories of none
(0), mild (1–3), moderate (4–6), and severe (7–10) using
methods described by Peirce and Cornell.23 Likelihood ratios
allow test results to be interpreted in different clinical popula-
tions.24,25 Multilevel, or stratum-specific, likelihood ratios are
advocated for evaluation of diagnostic tests with continuous
scores because they do not require scores to be forced into
dichotomous positive/negative outcomes.23,26,27
All data analysis was conducted with sampling weights to
adjust for oversampling of patients with pain screening NRS
scores≥1. Stata Intercooled version 8.2 (Stata Corp., College
Station, Tex) and Excel 2002 SP1 (Microsoft Corp., Redmond,
Wash) were used.
RESULTS
Research assistants approached 548 patients with an invita-
tion to participate. Of the 357 who initially agreed, 277 (78%)
were interviewed, and 275 (77%) were included in the analysis
(Fig. 1). One patient started but did not complete the interview.
The remainder either declined to be interviewed after the
physician visit or left the clinic without being interviewed.
Those who gave a reason cited lack of time or the need to go
elsewhere for further testing (e.g., laboratory or radiology).
Patients who were not interviewed after initially agreeing to
participate were more likely to have seen a resident physician
but had similar pain scores, reasons for the visit, and
demographics to completers.
Population characteristics
The mean age of participants was 55 years (Table 1). They were
socioeconomically diverse and had an average of 1.9 (95% CI
1.7–2.1) chronic medical conditions. Eighty percent saw the
physician they considered to be their “regular doctor,” and
47% saw a resident physician.
Forty percent reported a pain symptom as a reason for the
visit as either the main reason (22%) or a secondary concern
(18%). Among participants with a pain screening NRS≥1, the
mean score was 6.0 (95% CI 5.7–6.3). Most patients reported
musculoskeletal pain; the most common primary pain loca-
tions were lower extremity (21%) and back/neck (18%). Two
percent reported pain because of neuropathy. Fifty-five percent
of the overall sample and 77% of patients with pain reported at
548 Invited 
 to participate   







79 Refused or lost 
before interview 
1 Refused to finish 
interview 
275 Included in 
analysis   
2 No pain score in 
electronic medical 
record 
Figure 1. Patient recruitment
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least 1 pain symptom that had been persistent for 6 months or
longer.
The percentage of participants with clinically important pain
was 37% by the first definition (pain that interferes with
functioning) and 40% by the second definition (pain that
motivates a physician visit). Twenty-six percent met criteria
for both definitions.
Accuracy of pain screening
Accuracy for pain that interferes with functioning. The area
under the ROC curve for the pain screening NRS compared to
the primary reference standard (BPI interference≥5) was
0.76, indicating fair accuracy. Results were not substantially
different when the pain screening NRS was tested against
alternative BPI interference thresholds (area under curve
0.76–0.77).
The lowest possible cut point, a pain screening NRS score
of 1, was 69% sensitive (95% CI 60–78) and 78% specific
(95% CI 71–83) for functional interference. In other words,
nearly a third of patients with pain-related functional inter-
ference had an NRS score of 0. The usual pain screening NRS
cut point, 4, was slightly less sensitive (64%, 95% CI 54–72)
with a specificity of 83% (95% CI 77–88).
Multilevel likelihood ratios are shown in Table 2. The
likelihood ratio for a score of 0 was less than 1, which reduces
the probability of pain that interferes with functioning. Scores
in the 1–3 range do not provide additional information because
the likelihood ratio is near 1.0, whereas scores of 4–6 and 7–10
increase the probability of functional interference. For exam-
ple, if the pretest probability of pain-related functional inter-
ference for a given clinic patient was 40%, the posttest
probabilities corresponding to scores of 0, 1–3, 4–6, and 7–10
would be 21, 40, 64, and 79%, respectively.
Accuracy for pain that motivates a visit. The area under the
ROC curve for the pain screening NRS compared to the second
reference standard (pain reason for the visit) was 0.78, again
indicating fair accuracy. Twenty-one percent of patients who
reported pain as the main reason for the visit, and 28% of
those with any pain reason for the visit had a pain screening
NRS score of zero. Accordingly, the sensitivity of a pain
screening NRS score of 1 was 71% (95% CI 62–79), and the
specificity was 81% (95% CI 74–86). A pain screening NRS
score of 4 had a sensitivity of 63% (95% CI 54–72) and
specificity of 85% (95% CI 79–90). Likelihood ratios were
similar to those obtained using the first reference standard
(Table 2).
DISCUSSION
We found that the pain screening NRS had only modest
accuracy for identifying patients with clinically important pain
in an academic primary care clinic. Even a pain screening
cutoff score of 1 missed nearly a third of patients with clinically
important pain.
Why did the pain screening NRS miss patients with
clinically important pain? First, it is possible that this simple
measure cannot be expected to identify all clinically important
pain in primary care. Pain is a multidimensional experience,
and this dimensionality has important implications for its
measurement.8,28 In settings where pain is often chronic and
complex, the simple pain screening NRS may fail to identify
















BPI Brief pain inventory, NRS numeric rating scale
*Calculations used weighted counts to adjust for sampling design






Education No high school degree 24









Health insurance Medicaid and/or Medicare only 50
Private insurance‡ 32
None 18
Reason for visit Pain symptom 22
Nonpain symptom 12
Other reason 66
Chronic condition Hypertension 70
Diabetes 25
Arthritis 25















CAD Coronary artery disease, COPD chronic obstructive lung disease
*Results weighted to adjust for sampling design (over-sampling of
patients with pain screening NRS≥1). Percents within categories may
not total 100 because of rounding.
†Not working and receiving or applied for disability payments
‡Including those with private insurance plus Medicare
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patients with pain-related suffering driven by functional
limitations, illness worry, or other factors.
There are more focused potential explanations for the poor
performance of the pain screening NRS, including the time
frame and wording of the question. Because it focuses on
current pain, the NRS might miss intermittent symptoms. In
addition, we found that “pain” was not the preferred word for
some patients to describe their subjective experience. For
example, one participant reported difficulty answering the
questions because “I feel great discomfort, but it is different
than pain.”
To our knowledge, this is the first published study to
evaluate the accuracy of pain screening in primary care. Our
study has several strengths. First, we evaluated the most
commonly used pain screening measure under real primary
care clinical conditions. In addition, we collected detailed
prospective information about pain and recruited a diverse
group of primary care patients with a broad spectrum of pain
and other medical problems.
This study also has several potential limitations. First, there
is no well-established gold standard for clinically important
pain. However, we believe our strategy for operationalizing
clinically important pain is well supported by the available
literature and clinical experience. Functional impairment has
been used many times previously to classify pain severity.12–17
Pain as a reason for the visit was chosen as the second
definition because of its patient-centeredness and clinical
relevance. Whereas we recognize that not all clinically impor-
tant pain will be included in either of these definitions, we
believe a pain screening test should at least identify patients
with pain that is functionally impairing or motivates a visit.
Second, selection bias is a potential concern. Participants were
enrolled when the research assistant was available. In addi-
tion, 34% of invited patients declined to participate, and 14%
initially agreed but did not complete the interview. We do not
believe these factors biased our results. Clinic procedures and
staffing on study enrollment days did not differ from other
days, and enrollment was not limited to certain times or days
of the week. Patients who failed to complete the interview had
similar demographic characteristics, pain scores, and reasons
for the visit as completers. In addition, demographics of our
study participants closely matched those of the clinic popula-
tion. Finally, our findings are limited to a single academic
Internal Medicine clinic; thus, our results cannot be general-
ized to all primary care settings.
To date, there is little empirical support for the hypothesis
that routine assessment and documentation of pain will
improve pain management in primary care. A recent retro-
spective study found no improvement in quality of pain care at
a Veterans Affairs general medicine clinic after implementation
of the “Pain as the 5th Vital Sign” campaign, which uses a pain
intensity NRS to screen for pain.29
Universal pain screening may have substantial costs in
primary care, where numerous acute, chronic, and preventive
care priorities compete for limited physician and nursing
time.30 For example, primary care physicians do not have time
to complete even the preventive services that have been
rigorously evaluated and recommended by the USPSTF.31 In
this resource limited environment, mandated initiatives like
universal pain assessment may have unintended effects on
patient care, clinic efficiency, clinician and patient satisfaction,
and medicolegal risk.
In conclusion, the practice of universal pain screening has
become widespread despite a lack of published research
evaluating the accuracy and effectiveness of pain screening
strategies. Our results suggest that the most commonly used
measure for pain screening may have only modest accuracy for
identifying patients with clinically important pain in primary
care. Further research is needed to determine whether pain
screening improves patient outcomes in primary care.
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